⌘K
Loading ticker…
Myriad Genetics Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Myriad Genetics Inc (MYGN) has a 3-month relative strength percentile of 79 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.4%, relative volume 2.91×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 79, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
MYGN is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $12M notional. Top 3 carry $32M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $12M |
| IWMiShares Russell 2000 ETF | 0.01% | $10M |
| XBIState Street SPDR S&P Biotech ETF | 0.13% | $10M |
| VXFVanguard Extended Market ETF | 0.01% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $547K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MYGN Jan avg: 7.87% median: 2.08% win: 50% σ: 20.91% n: 4 2022-04-12 → 2026-05-29 | MYGN Feb avg: -9.87% median: -9.68% win: 0% σ: 7.93% n: 4 2022-04-12 → 2026-05-29 | MYGN Mar avg: 1.23% median: -0.26% win: 50% σ: 16.56% n: 4 2022-04-12 → 2026-05-29 | MYGN Apr avg: -8.22% median: -8.35% win: 20% σ: 8.47% n: 5 2022-04-12 → 2026-05-29 | MYGN May avg: -9.22% median: -6.15% win: 40% σ: 22.63% n: 5 2022-04-12 → 2026-05-29 | MYGN Jun avg: 8.43% median: 6.27% win: 75% σ: 13.45% n: 4 2022-04-12 → 2026-05-29 (current) | MYGN Jul avg: 7.07% median: 5.38% win: 50% σ: 30.70% n: 4 2022-04-12 → 2026-05-29 | MYGN Aug avg: 7.93% median: -7.01% win: 50% σ: 39.71% n: 4 2022-04-12 → 2026-05-29 | MYGN Sep avg: -3.64% median: -6.73% win: 25% σ: 12.33% n: 4 2022-04-12 → 2026-05-29 | MYGN Oct avg: -0.70% median: 2.92% win: 50% σ: 14.15% n: 4 2022-04-12 → 2026-05-29 | MYGN Nov avg: -2.70% median: -3.71% win: 25% σ: 19.84% n: 4 2022-04-12 → 2026-05-29 | MYGN Dec avg: -15.81% median: -17.57% win: 25% σ: 11.96% n: 4 2022-04-12 → 2026-05-29 |